Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
Open Access
- 29 August 2021
- journal article
- review article
- Published by Elsevier BV in The Lancet Regional Health - Americas
- Vol. 2, 100062
- https://doi.org/10.1016/j.lana.2021.100062
Abstract
No abstract availableThis publication has 74 references indexed in Scilit:
- Quantifying the risk of error when interpreting funnel plotsSystematic Reviews, 2015
- A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validationSystematic Reviews, 2014
- GRADE guidelines 6. Rating the quality of evidence—imprecisionJournal of Clinical Epidemiology, 2011
- The Number of Patients and Events Required to Limit the Risk of Overestimation of Intervention Effects in Meta-Analysis—A Simulation StudyPLOS ONE, 2011
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- GRADE guidelines: 3. Rating the quality of evidenceJournal of Clinical Epidemiology, 2011
- What is “quality of evidence” and why is it important to clinicians?BMJ, 2008
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Quantifying heterogeneity in a meta-analysisStatistics in Medicine, 2002
- Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysisBMJ, 2001